Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
ABCL holding history
AbCellera Biologics Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABCL overviewAll 13F holders of ABCLFull Q4 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −13,112−100.0% | Sold out | Holders |
| Q4 2023 | 13,112 | $74.9K | <0.1% | +13,112 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −989,154−100.0% | Sold out | Holders |
| Q1 2023 | 989,154 | $7.46M | <0.1% | +12,597+1.3% | Added | Holders |
| Q4 2022 | 976,557 | $9.89M | <0.1% | +97,665+11.1% | Added | Holders |
| Q3 2022 | 878,892 | $8.69M | <0.1% | −15,282−1.7% | Reduced | Holders |
| Q2 2022 | 894,174 | $9.52M | <0.1% | +894,174 | New | Holders |